2633 — Jacobson Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.35bn
- HK$3.64bn
- HK$1.58bn
- 91
- 74
- 97
- 99
Annual cashflow statement for Jacobson Pharma, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 221 | 231 | 340 | 255 | — |
| Depreciation | |||||
| Non-Cash Items | 24.6 | 17.3 | 66.6 | 144 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -27.6 | -34.4 | 39.2 | -70.7 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 409 | 407 | 630 | 484 | — |
| Capital Expenditures | -63.4 | -63.9 | -63 | -130 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -310 | 13.9 | -72 | 173 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -373 | -49.9 | -135 | 43.3 | — |
| Financing Cash Flow Items | 14.3 | -26.6 | -72.4 | -81.2 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 21.4 | -358 | -36.6 | -1,053 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 58.9 | -1.7 | 458 | -524 | — |